ChromaDex Corporation discovers, acquires, develops, and commercializes proprietary-based ingredient technologies. The Company allows its business units to discover, acquire, develop and commercialize ingredient technologies that address the dietary supplement, food, beverage, skin care and pharmaceutical markets. The Company operates through three segments: Ingredients, which develops, supplies and commercializes ingredient technologies; Core standards and contract services, which supplies phytochemical reference standards; and Scientific and regulatory consulting, which provides scientific and regulatory consulting to the clients in the food, supplement and pharmaceutical industries to manage health and regulatory risks.

Type
Public
HQ
Irvine, US
Founded
1999
Size (employees)
84 (est)+5%
ChromaDex was founded in 1999 and is headquartered in Irvine, US
Report incorrect company information

Key People/Management at ChromaDex

Frank L. Jaksch Jr.

Frank L. Jaksch Jr.

Chief Executive Officer & Co-Founder
Robert Fried

Robert Fried

President, CSO, Executive Director

ChromaDex Office Locations

ChromaDex has offices in Rockville, Longmont and Irvine
Irvine, US (HQ)
10005 Muirlands Blvd
Longmont, US
350 1751 S Fordham St
Rockville, US
310 11821 Parklawn Dr
Show all (3)
Report incorrect company information

ChromaDex Financials and Metrics

ChromaDex Financials

ChromaDex's revenue was reported to be $21.20 m in FY, 2017
USD

Revenue (Q1, 2018)

6.6 m

Gross profit (Q1, 2018)

3.1 m

Gross profit margin (Q1, 2018), %

47.8%

Net income (Q1, 2018)

(8.4 m)

EBIT (Q1, 2018)

(8.4 m)

Market capitalization (14-Jun-2018)

203 m

Closing share price (14-Jun-2018)

3.7

Cash (31-Mar-2018)

41 m
ChromaDex's current market capitalization is $203 m.
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Revenue

10.2 m15.3 m22 m26.8 m21.2 m

Revenue growth, %

51%44%22%

Cost of goods sold

7 m10 m13.5 m14.9 m10.7 m

Gross profit

3.1 m5.3 m8.5 m11.9 m10.5 m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q3, 2015Q1, 2016Q2, 2015Q3, 2016Q1, 2016Q2, 2016Q1, 2017Q2, 2017Q1, 2018

Revenue

2.7 m3.1 m3.9 m4.1 m6.3 m5.3 m6.1 m5 m7.3 m8.8 m4.4 m5.3 m6.6 m

Cost of goods sold

2 m2.1 m2.5 m2.6 m3.8 m3.3 m3.6 m3 m3.9 m4.7 m2.7 m3 m3.4 m

Gross profit

750.2 k985 k1.4 m1.5 m2.5 m1.9 m2.5 m2 m3.5 m4.1 m1.8 m2.3 m3.1 m

Gross profit Margin, %

28%32%36%37%39%37%40%41%47%47%39%43%48%
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

2.3 m4 m5.5 m1.6 m45.4 m

Accounts Receivable

Inventories

2.2 m3.7 m8.2 m7.9 m5.8 m

Current Assets

5.8 m9.9 m16.5 m15.7 m57.2 m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q3, 2015Q1, 2016Q2, 2015Q3, 2016Q1, 2016Q2, 2016Q1, 2017Q2, 2017Q1, 2018

Cash

1.1 m1.9 m1.3 m1.2 m4.7 m3.2 m5.7 m2.3 m3 m3.4 m1.2 m14.1 m41 m

Inventories

2.2 m2.5 m2.9 m2.3 m4.2 m3.2 m3.1 m6.3 m6.7 m4.5 m8.9 m7.8 m5.1 m

Current Assets

4.7 m6.4 m6.6 m6.3 m13 m9.1 m12.3 m15.5 m14.4 m15.2 m15.6 m27.4 m52.6 m

Total Assets

7.8 m8.5 m8.9 m8.7 m15 m11 m14.2 m18.8 m16.5 m17.8 m21.1 m32.9 m57.4 m
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

(4.4 m)(5.4 m)(2.8 m)(2.9 m)(11.4 m)

Inventories

(466.4 k)(1.5 m)(4.4 m)240.9 k2.2 m

Accounts Payable

(1.6 m)2.2 m2.8 m(245.7 k)(2.4 m)

Cash From Operating Activities

(3.9 m)(2.6 m)(2.1 m)(2.9 m)(9.8 m)
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q3, 2015Q1, 2016Q2, 2015Q3, 2016Q1, 2016Q2, 2016Q1, 2017Q2, 2017Q1, 2018

Net Income

(1.3 m)(1.8 m)(1.7 m)(659.7 k)(3.7 k)(1 m)(1.3 m)(781.4 k)255.6 k173 k(1.9 m)(4.7 m)(8.4 m)

Inventories

2.9 m2.3 m4.2 m3.2 m645.3 k1.8 m1.5 m3.6 m8.9 m179.4 k733 k

Accounts Payable

2.8 m2.3 m3.6 m2.6 m(357.1 k)(2.1 m)(3.3 m)(3.9 m)7.9 m(3 m)2.1 m

Cash From Operating Activities

(497.2 k)(3.1 m)(2.9 m)(3 m)(5.6 m)(4 m)
USDY, 2018

Financial Leverage

1.2 x
Show all financial metrics
Report incorrect company information

ChromaDex Online and Social Media Presence

Embed Graph
Report incorrect company information

ChromaDex News and Updates

United States Pterostilbene Sales Market Industry: United States Market Size, Growth, Trends and 2023 Forecast Report

United States Pterostilbene Market report provides vital information on every parameter which is required for making strategic decisions and development of every business in policies.United States players are growing their existence, native vendors are result it tough to contest with them, particul…
Report incorrect company information